Literature DB >> 17952576

Family-based detection for hereditary hemochromatosis.

Michele Reyes1, Diane O Dunet, Karen Bandel Isenberg, Michael Trisolini, Diane K Wagener.   

Abstract

The purpose of this study was to examine motivators for and barriers to family-based detection for hereditary hemochromatosis (HH). HH patients (n = 60) and HH siblings (n = 25) participated in one-on-one or group interviews. Patients and siblings understood that HH "runs in families," but not that siblings are at higher HH risk than other family members. Patient motivators included concern for siblings' health, seriousness of untreated HH, and doctor's encouragement to tell siblings that they need to seek diagnostic testing. Siblings were motivated by the seriousness of HH. Barriers included lack of symptoms, belief that HH was rare, and assumption that their doctor would have mentioned the risk of HH. Family-based detection continues to be a feasible part of an overall public health strategy to promote early detection of HH. Greater awareness of HH and its potential consequences, especially among high-risk groups, provides an additional potential avenue for public health action.

Entities:  

Mesh:

Year:  2007        PMID: 17952576     DOI: 10.1007/s10897-007-9130-3

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  14 in total

Review 1.  EASL International Consensus Conference on Haemochromatosis.

Authors:  P Adams; P Brissot; L W Powell
Journal:  J Hepatol       Date:  2000-09       Impact factor: 25.083

2.  Research priorities for evaluating family history in the prevention of common chronic diseases.

Authors:  Paula W Yoon; Maren T Scheuner; Muin J Khoury
Journal:  Am J Prev Med       Date:  2003-02       Impact factor: 5.043

Review 3.  Family-centered approaches to understanding and preventing coronary heart disease.

Authors:  Sharon L R Kardia; Stephen M Modell; Patricia A Peyser
Journal:  Am J Prev Med       Date:  2003-02       Impact factor: 5.043

Review 4.  Effecting behavior change: awareness of family history.

Authors:  Janet Audrain-McGovern; Chanita Hughes; Freda Patterson
Journal:  Am J Prev Med       Date:  2003-02       Impact factor: 5.043

Review 5.  Reconsidering the family history in primary care.

Authors:  Eugene C Rich; Wylie Burke; Caryl J Heaton; Susanne Haga; Linda Pinsky; M Priscilla Short; Louise Acheson
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

6.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

7.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

8.  Family Communication and Genetic Counseling: The Case of Hereditary Breast and Ovarian Cancer.

Authors:  J Green; M Richards; F Murton; H Statham; N Hallowell
Journal:  J Genet Couns       Date:  1997-03       Impact factor: 2.537

9.  Disclosure of familial genetic information: perceptions of the duty to inform.

Authors:  L S Lehmann; J C Weeks; N Klar; L Biener; J E Garber
Journal:  Am J Med       Date:  2000-12-15       Impact factor: 4.965

10.  Communication about carrier testing within hemophilia A families.

Authors:  James R Sorenson; Tracey Jennings-Grant; Jamie Newman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2003-05-15       Impact factor: 3.908

View more
  2 in total

1.  Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.

Authors:  Barbara A Bernhardt; Cara Zayac; Reed E Pyeritz
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

2.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.